Priorities for developing countries in the global response to non-communicable diseases

Globalization and Health

Nigel Unwin¹  Nathan Ford²  Dermot Maher³ 

[1] Faculty of Medical Sciences, University of The West Indies Cave Hill Campus, Bridgetown, Barbados;Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa;London School of Hygiene and Tropical Medicine, Keppel Street, London, England

关键词: Treatment;    Prevention;    Non-communicable diseases;   

Others  :  819506
DOI  :  10.1186/1744-8603-8-14

 received in 2011-09-21, accepted in 2012-05-29,  发布年份 2012

【 摘 要 】

The growing global burden of non communicable diseases (NCDs) is now killing 36 million people each year and needs urgent and comprehensive action. This article provides an overview of key critical issues that need to be resolved to ensure that recent political commitments are translated into practical action. These include: (i) categorizing and prioritizing NCDs in order to inform donor funding commitments and priorities for intervention; (ii) finding the right balance between the relative importance of treatment and prevention to ensure that responses cover those at risk, and those who are already sick; (iii) defining the appropriate health systems response to address the needs of patients with diseases characterized by long duration and often slow progression; (iv) research needs, in particular translational research in the delivery of care; and (v) sustained funding to support the global NCD response.

【 授权许可】

   
2012 Maher et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]World Health Organization: Global infobase. https://apps.who.int/infobase/mortality.aspx2 webcite
• [2]World Health Organization: Global status report on non-communicable diseases. 2010. http://whqlibdoc.who.int/publications/2011/9789240686458_eng.pdf webcite
• [3]Geneau R, Stuckler D, Stachenco S: Raising the priority of preventing chronic diseases: a political process. Lancet 2010, 376:1689-1698.
• [4]Suhrcke M, Nugent RA, Stuckler D, Rocco L: Chronic disease: an economic perspective. Oxford Health Alliance, London; 2006.
• [5]Adeyi O, Smith O, Robles S: Public policy and the challenge of chronic non-communicable diseases. World Bank, Washington, DC; 2002.
• [6]General Assembly of the United Nations: High-level Meeting on Non-communicable Diseases. http://www.un.org/en/ga/president/65/issues/ncdiseases.shtml webcite
• [7]Strong K, Mathers C, Leeder S, Beaglehole R: Preventing chronic diseases: how many lives can we save? Lancet 2005, 366:1578-1582.
• [8]Narayan KMV, Zhang P, Kanaya AM, et al.: Diabetes: the pandemic and potential solutions. In Disease control priorities in developing countries. 2nd edition. Edited by Jamison DT, Breman JG, Measham AR. Washington, DC, The World Bank; 2006.
• [9]Gaziano TA, Reddy KS, Paccaud F, Horton S, Chaturvedi V: Cardiovascular disease. In Disease control priorities in developing countries. 2nd edition. Edited by Jamison DT, Breman JG, Measham AR. Washington, DC, The World Bank; 2006.
• [10]Lim SS, Gaziano TA, Gakidou E, et al.: Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet 2007, 370:2054-2062.
• [11]World Health Organization: 2008–2013 Action Plan for the Global Strategy for the Prevention and Control of Noncommunicable Diseases. WHO, Geneva; 2008.
• [12]World Health Organization: Sixty-fourth World Health Assembly. Document A64/21. WHO, Geneva; 2011.
• [13]Maher D, Harries A, Zachariah R, Enarson D: A global framework for action to improve the primary care response to chronic non-communicable diseases: a solution to a neglected problem. BMC Publ Health 2009, 9:355. BioMed Central Full Text
• [14]Farmer P, Frenk J, Knaul FM, et al.: Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet 2010, 376:1186-1193.
• [15]First Global Ministerial Conference on NCDs and Healthy Lifestyles. 2011. http://www.who.int/nmh/events/moscow_ncds_2011/en/ webcite
• [16]Piot P, Ebrahim S: Prevention and control of chronic diseases. Br Med J 2010, 342:293-294.
• [17]Beaglehole R, Bonita R, Horton R, et al.: Priority actions for the non-communicable disease crisis. Lancet 2011, 377:1438-1447.
• [18]General Assembly of the United Nations: High-level Meeting on AIDS. 2006. http://www.un.org/ga/aidsmeeting2006 webcite
• [19]Maher D: Implications of the global financial crisis for the response to diseases of poverty within overall health sector development: the case of tuberculosis. Trop Med Int Health 2010, 15(1):11-17.
• [20]Maher D, von Schoen-Angerer T, Cohn J: Crunch time for funding of universal access to antiretroviral treatment for people with HIV infection. Int J Clin Pract 2011, 65:824-827.
• [21]Bemelmans M, van de Akker T, Ford N, Philips M, Zachariah R, Harries A, Schouten E, Hermann K, Mwagomba B, Massaquoi M: Providing universal access to antiretroviral therapy in Thyolo, Malawi through task shifting and decentralization of HIV/AIDS care. Trop Med Int Health 2010, 12:1413-1420.
• [22]Wilkinson D, Wilkinson NF: Organisation of non-communicable disease care. In Principles of medicine in Africa. 3rd edition. Edited by Parry E, Godfrey R, Mabey D, Gill G. Cambridge University Press, Cambridge; 2004.
• [23]Maher D: Re-thinking global health sector efforts for HIV and tuberculosis epidemic control: promoting integration of programme activities within a strengthened health system. BMC Publ Health 2010, 10:394.
• [24]Allotey P, Reidpath DD, Yasin S, Chan CK, Aikins AD: Rethinking health-care systems: a focus on chronicity. Lancet 2011, 377:450-451.
• [25]Rawaf S, De Maeseneer J, Starfield B: From Alma-Ata to Almaty: a new start for primary health care. Lancet 2008, 372:1365-1367.
• [26]World Health Organization: The world health report 2008: primary health care, now more than ever. WHO, Geneva; 2008.
• [27]Jha P: Control of non-communicable diseases in sub-Saharan Africa. Disease Control Priorities Project.http://www.dcp2.org/file/203/djcc_jha.pdf webcite
• [28]Maher D, Smeeth L, Sekajugo J: Health transition in Africa: practical policy proposals for primary care. Bull World Health Organ 2010, 88:943-948.
• [29]Maher D, Harries AD: Quality care: a link between clinical and public health approaches to HIV infection in developing countries. Trop Med Int Health 2010, 15(4):391-395.
• [30]Maher D: Tuberculosis control: good clinical care and good public health. In Tuberculosis handbook. Edited by Kaufmann S, Rubin E, Britton W, Helden P. Mannheim, Germany, Wiley-VCH; 2008.
• [31]World Health Organization: Antiretroviral therapy for HIV infection in adults and adolescents. WHO, Geneva; 2010. http://whqlibdoc.who.int/publications/2010/9789241599764_eng.pdf webcite
• [32]Maher D: Standardised interventions in international health: Procrustes, where are you now? Trop Med Int Health 2009, 14(11):1-3.
• [33]Gilks CF, Crowley S, Ekpini R, Gove S, Perriens J, Souteyrand Y, Sutherland D, Vitoria M, Guerma T, de Cock K: The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 2006, 368:505-510.
• [34]World Health Organization: Global tuberculosis control: WHO Report 2010. WHO, Geneva; 2010. http://whqlibdoc.who.int/publications/2010/9789241564069_eng.pdf webcite
• [35]World Health Organization: Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: progress report 2010. 2010. http://www.who.int/hiv/pub/2010progressreport/en/ webcite
• [36]Joint United Nations Programme on HIV/AIDS: Chronic care for HIV and non-communicable diseases. How to leverage the HIV experience. UNAIDS, Geneva; 2011. http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2011/20110526_JC2145_Chronic_care_of_HIV.pdf webcite
• [37]Maher D, Sekajugo J, Harries AD, Grosskurth H: Research needs for an improved primary care response to chronic non-communicable diseases in Africa. Tropical Medicine and International Health 2010, 15(2):176-181.
• [38]Young F, Critchley JA, Johnstone LK, Unwin NC: A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and diabetes mellitus, HIV and metabolic syndrome, and the impact of globalization. Global Health 2009, 5:9. 10.1186/1744-8603-5-9 PMID:19751503
• [39]Mendis S, Fukino K, Cameron A, et al.: The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull World Health Organ 2007, 85:279-288.
• [40]Ait-Khaled N, Auregan G, Bencharif N, Mady Carmara L, Dagli E, Djankine K, Keita B, Ky C, Mahi S, Ngoran K, Pham DL, Sow O, Yousser M, Zidouni N, Enarson DA: Affordability of inhaled corticosteroids as a potential barrier to treatment of asthma in some developing countries. Int J Tuberc Lung Dis 2000, 4:268-271.
• [41]Asthma Drugs Facilityhttp://www.globaladf.org/ webcite
• [42]Global Drug Facility for anti-tuberculosis drugs. http://www.stoptb.org/gdf/ webcite
• [43]Ford N, Calmy A, Mills E: The first decade of antiretroviral therapy in Africa. Glob Heal 2011, 7:33.
• [44]Ford N, Roberts T, Calmy A: Viral load monitoring in resource-limited settings: a medical and public health priority. AIDS 2012. [in press]
• [45]Zachariah R, Ford N, Maher D, Bissel K, van Den Bergh R, van Den Boogaard W, et al.: Is operational research delivering the goods? Assessing the journey from generating evidence to policy and practice change in low-income countries? Lancet Infect Dis 2012, 12:415-421.
• [46]The global alliance for chronic diseases Lancet 2009, 373:2084.
• [47]Maher D, Sekajugo J: Research on health transition in Africa: time for action. Health Research, Policy and Systems 2011, 9:5.
• [48]Maher D, Waswa L, Baisley K, Karabarinde A, Unwin N, Grosskurth H: Distribution of hyperglycaemia and related cardiovascular disease risk factors in low-income countries: a cross-sectional population-based survey in rural Uganda. Int J Epidemiol 2010, 1-12.
• [49]Maher D, Waswa L, Baisley K, Karabarinde A, Unwin N: Epidemiology of hypertension in low-income countries: a cross-sectional population-based survey in rural Uganda. J Hypertens 2011, 29:1061-1068.
• [50]World Bank: World development report 1993: investing in health. Oxford University Press, New York; 1993.
• [51]Schwartländer B, Stover J, Hallett T, Atun R, Avila C, Gouws E, et al.: Towards an improved investment approach for an effective response to HIV/AIDS. Lancet 2011. early online publication
• [52]World Health Organization: The world health report 2004: changing history. WHO, Geneva; 2004.
• [53]Nugent RA, Yach D, Feigl AB: Noncommunicable diseases and the Paris Declaration. Lancet 2009, 374:784-785.
• [54]Ooms G, Van Damme W, Baker BK, Zeitz P, Schrecker T: The ‘diagonal’ approach to Global Fund financing: a cure for the broader malaise of health systems? Global Health 2008, 4:6.
• [55]Mills EJ, Ford N: Political lessons from the global HIV/AIDS response to inform a rapid non-communicable disease response. AIDS 2012, 26:1171-1173.